Derisked pipeline
Every founder is ACE-scored on real execution data — usage, retention, pipeline. No vanity metrics.
● Investor relations
Structured deal-flow. Not pitch decks.
AWA gives capital allocators a measured, mandate-matched view of African early-stage execution — sourced from ACE telemetry, not founder self-report.
$47M
Capital matched YTD
312
Active ventures
89%
Cohort survival 12mo
< 14d
Intro to first call
Mandate-matched
Filter by sector, geography, stage, ticket size. Get notified the moment a venture clears your criteria.
Live cohort data
Track cohort-level traction live. See which sectors are compounding before the market does.
Audit-grade docs
Standardised data rooms, common cap table format, harmonised KYC across all hubs.
● Cohort calendar
Quarterly demo days.
| QUARTER | VENTURES | ACE HEALTH | |
|---|---|---|---|
| Q1 2026 | 28 | 82 median | |
| Q4 2025 | 24 | 84 median | |
| Q3 2025 | 31 | 79 median |
● ACCESS THE PIPELINE
Get on the deal-flow list.
Quarterly digest, on-demand cohort access, direct intros to mandate-fit founders.